Ultragenyx Pharmaceutical Inc. Insider Trading for February 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ultragenyx Pharmaceutical Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Ultragenyx Pharmaceutical Inc. for February 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 11 2014 | RARE | Ultragenyx Pharmac ... | Kassberg Thomas Richard | Chief Business Offi ... | Option Exercise | C | 0.00 | 98,595 | 0 | 0 | |
| Feb 11 2014 | RARE | Ultragenyx Pharmac ... | Kassberg Thomas Richard | Chief Business Offi ... | Buy | C | 0.00 | 31,454 | 0 | 125,804 | 94.4 K to 125.8 K (+33.34 %) |
| Feb 07 2014 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Option Exercise | J | 3.01 | 29,108 | 87,615 | 0 | |
| Feb 07 2014 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Option Exercise | J | 0.96 | 91,241 | 87,500 | 0 | |
| Feb 07 2014 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Option Exercise | J | 3.01 | 41,583 | 125,165 | 0 | |
| Feb 07 2014 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Option Exercise | J | 0.96 | 130,344 | 125,000 | 0 | |
| Feb 07 2014 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Option Exercise | J | 3.01 | 24,950 | 75,100 | 0 | |
| Feb 07 2014 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Option Exercise | J | 0.96 | 78 | 75 | 0 | |
| Feb 07 2014 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Option Exercise | J | 3.01 | 83,039 | 249,947 | 0 | |
| Feb 07 2014 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Option Exercise | J | 0.96 | 260,688 | 250,000 | 0 | |
| Feb 07 2014 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Option Exercise | C | 0.00 | 1,956,686 | 0 | 0 | |
| Feb 07 2014 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Buy | C | 0.00 | 624,240 | 0 | 624,240 | 0 to 624.2 K |
| Feb 07 2014 | RARE | Ultragenyx Pharmac ... | TPG Group Holdings (SBS) Advis ... | 10% Owner | Option Exercise | C | 0.00 | 541,634 | 0 | 0 | |
| Feb 07 2014 | RARE | Ultragenyx Pharmac ... | TPG Group Holdings (SBS) Advis ... | 10% Owner | Option Exercise | C | 0.00 | 9,129,063 | 0 | 0 | |
| Feb 07 2014 | RARE | Ultragenyx Pharmac ... | TPG Group Holdings (SBS) Advis ... | 10% Owner | Buy | C | 0.00 | 3,085,240 | 0 | 3,085,240 | 0 to 3.1 M |
| Feb 05 2014 | RARE | Ultragenyx Pharmac ... | FMR LLC | 10% Owner | Option Exercise | C | 0.00 | 541,634 | 0 | 0 | |
| Feb 05 2014 | RARE | Ultragenyx Pharmac ... | FMR LLC | 10% Owner | Option Exercise | C | 0.00 | 9,129,063 | 0 | 0 | |
| Feb 05 2014 | RARE | Ultragenyx Pharmac ... | FMR LLC | 10% Owner | Buy | P | 21.00 | 175,000 | 3,675,000 | 3,260,240 | 3.1 M to 3.3 M (+5.67 %) |
| Feb 05 2014 | RARE | Ultragenyx Pharmac ... | FMR LLC | 10% Owner | Buy | C | 0.00 | 172,797 | 0 | 3,085,240 | 2.9 M to 3.1 M (+5.93 %) |
| Feb 05 2014 | RARE | Ultragenyx Pharmac ... | FMR LLC | 10% Owner | Buy | C | 0.00 | 2,912,443 | 0 | 2,912,443 | 0 to 2.9 M |
| Feb 03 2014 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Senior Vice P ... | Buy | P | 21.00 | 4,500 | 94,500 | 84,255 | 79.8 K to 84.3 K (+5.64 %) |
| Feb 03 2014 | RARE | Ultragenyx Pharmac ... | Fust Matthew K | Director | Option Exercise | A | 21.00 | 17,500 | 367,500 | 17,500 | |
| Feb 03 2014 | RARE | Ultragenyx Pharmac ... | Fust Matthew K | Director | Buy | P | 21.00 | 5,000 | 105,000 | 5,000 | 0 to 5 K |
| Feb 03 2014 | RARE | Ultragenyx Pharmac ... | Kassberg Thomas Richard | Chief Business Offi ... | Buy | P | 21.00 | 1,500 | 31,500 | 94,350 | 92.9 K to 94.4 K (+1.62 %) |
| Feb 03 2014 | RARE | Ultragenyx Pharmac ... | Nadav Eran | Director | Option Exercise | A | 21.00 | 17,500 | 367,500 | 17,500 | |
| Feb 03 2014 | RARE | Ultragenyx Pharmac ... | Steen Marten | Director | Option Exercise | A | 21.00 | 17,500 | 367,500 | 17,500 | |
| Feb 03 2014 | RARE | Ultragenyx Pharmac ... | SIEGALL CLAY B | Director | Option Exercise | A | 21.00 | 17,500 | 367,500 | 17,500 | |
| Feb 03 2014 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Option Exercise | A | 21.00 | 17,500 | 367,500 | 17,500 | |
| Feb 03 2014 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Buy | P | 21.00 | 5,000 | 105,000 | 36,903 | 31.9 K to 36.9 K (+15.67 %) |